As of Nov 21
| +0.02 / +0.54%|
The 3 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +143.24% increase from the last price of 3.70.
The current consensus among 3 polled investment analysts is to Buy stock in Tonix Pharmaceuticals Holding Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.